ANI Pharmaceuticals, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for ANI Pharmaceuticals, Inc. (ANIP) is 2.91

According to ANI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.91. This represents a change of 2.84% compared to the average of 2.83 of the last 4 quarters.

ANI Pharmaceuticals, Inc. (ANIP) Historical Current Ratio (quarterly & annually)

How has ANIP Current Ratio performed in the past?

The mean historical Current Ratio of ANI Pharmaceuticals, Inc. over the last ten years is 2.89. The current 2.91 Current Ratio has changed 0.84% with respect to the historical average. Over the past ten years (40 quarters), ANIP's Current Ratio was at its highest in in the June 2017 quarter at 3.99. The Current Ratio was at its lowest in in the March 2019 quarter at 0.92.

ANI Pharmaceuticals, Inc. (ANIP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ANI Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ANI Pharmaceuticals, Inc. (ANIP) Average Current Ratio

How has ANIP Current Ratio performed in the past?

The current Current Ratio of ANI Pharmaceuticals, Inc. (ANIP) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

ANI Pharmaceuticals, Inc. (ANIP) Current Ratio vs. Peers

How is ANIP’s Current Ratio compared to its peers?

ANI Pharmaceuticals, Inc.’s Current Ratio is greater than Amphastar Pharmaceuticals, Inc. (2.40), greater than Bausch Health Companies Inc. (1.56), greater than Amneal Pharmaceuticals, Inc. (1.87), greater than Viatris Inc. (1.58), greater than Dr. Reddy's Laboratories Limited (1.93), greater than Teva Pharmaceutical Industries Limited (0.95), greater than Harrow Health, Inc. (2.24), greater than Collegium Pharmaceutical, Inc. (1.03), less than Lifecore Biomedical, Inc. (3.84), greater than Evolus, Inc. (1.42),

Build a custom stock screener for ANI Pharmaceuticals, Inc. (ANIP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ANI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ANI Pharmaceuticals, Inc. (ANIP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ANI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.